Tarsus Pharmaceuticals Inc Earnings

The next earnings date for Tarsus Pharmaceuticals Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tarsus Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.36

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tarsus Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$-0.48	-26.78%
05/06/2025	Before Market	$-0.64	-1.59%
02/25/2025	Before Market	$-0.60	26.44%
11/07/2024	After Market	$-0.61	35.11%
08/08/2024	After Market	$-0.88	4.35%
05/08/2024	After Market	$-1.01	15.83%
02/27/2024	Before Market	$-1.31	3.68%
11/09/2023	After Market	$-1.28	6.57%
08/10/2023	After Market	$-1.17	-8.33%
05/09/2023	After Market	$-0.88	6.38%
03/13/2023	After Market	$-0.49	28.99%
11/09/2022	Before Market	$-0.84	13.40%
08/11/2022	After Market	$-0.24	59.32%
05/10/2022	After Market	$-0.98	-6.52%
03/14/2022	After Market	$-0.72	1.37%
11/09/2021	After Market	$-0.76	-76.74%
08/04/2021	After Market	$0.33	168.75%
05/11/2021	After Market	$0.47	173.44%
03/31/2021	After Market	$-0.68	-3.03%
11/24/2020	After Market	$-3.71	-642.00%
09/02/2020	---	$-0.19	---

More About Tarsus Pharmaceuticals Inc

Website

https://www.tarsusrx.com

Country

USA

Full Time Employees

323

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

“Tarsus Pharmaceuticals Inc Earnings” Can Refer to the Tarsus Pharmaceuticals Inc Earnings Date

Some people say “Tarsus Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tarsus Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tarsus Pharmaceuticals Inc Stock on the Earnings Date

If you own Tarsus Pharmaceuticals Inc stock (TARS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tarsus Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tarsus Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tarsus Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Tarsus Pharmaceuticals Inc earnings or anything else related to the stock market.